...
机译:用BRAF抑制剂vemureafenib治疗难治性BRAF(V600E)突变的朗格汉斯细胞组织细胞症的皮肤不良事件:欧洲队列研究
Ctr Hosp Univ Grenoble Alpes Dept Dermatol Grenoble France;
Ctr Hosp Univ Grenoble Alpes Dept Dermatol Grenoble France;
Ctr Hosp Univ Lille Dept Dermatol Lille France;
PIFO Univ Versailles St Quentin CHU R Poincare Fac Med Serv Pharmacol Toxicol Garches France;
Cambridge Univ Hosp Dept Pediat Oncol &
Hematol Cambridge England;
St Anna Childrens Hosp Dept Pediat Oncol &
Hematol Vienna Austria;
Azienda Osped Univ A Meyer Dipartimento Oncoematol Pediat Florence Italy;
St Joseph Univ Ctr Hosp Nord Div Pediat Hematol Oncol Beirut Lebanon;
Trousseau Hosp French Reference Ctr Langerhans Cell Histiocytosi Paris France;
Newcastle Univ Inst Cellular Med Newcastle Upon Tyne Tyne &
Wear England;
Hop La Pitie Salpetriere Med Interne Paris France;
Univ Paris Saclay UVSQ EA4340 Boulogne France;
Ctr Hosp Univ Felix Guyon St Denis St Denis La Reunion France;
Brastislava Univ Bratislava Slovakia;
Ctr Hosp Univ Grenoble Dept Pediat Hematol &
Oncol Grenoble France;
Ctr Hosp Univ Grenoble Alpes Dept Dermatol Grenoble France;
Ctr Hosp Univ Grenoble Alpes Dept Dermatol Grenoble France;
Ctr Hosp Univ Bordeaux Dept Pediat Hematol &
Oncol Bordeaux France;
Ctr Hosp Univ Bordeaux Dept Pediat Hematol &
Oncol Bordeaux France;
Ctr Hosp Univ Toulouse Dept Pediat Hematol &
Oncol Toulouse France;
Ctr Hosp Univ Amiens Dept Pediat Hematol &
Oncol Amiens France;
Univ Klinikum Frankfurt Theodor Klin Kinder &
Jugendmed Frankfurt Germany;
Hop Univ Enfants Reine Fabiola Hematooncol Immunol &
Transplantat Brussels Belgium;
Univ Hosp Minsk Minsk BELARUS;
Univ Klinikum Munster Klin Kinder &
Jugendmed Padiat Hamatol &
Onkol Munster Germany;
Ctr Hosp Univ Poitiers Dept Pediat Hematol &
Oncol Poitiers France;
Cambridge Univ Hosp Dept Pediat Oncol &
Hematol Cambridge England;
Ctr Hosp Univ Lille Dept Pediat Hematol &
Oncol Lille France;
Charite Univ Med Berlin Campus Virchow Klinikum Pediat Hematol Oncol &
Stem Cell Transplantat;
Univ Hosp Motol Prague Czech Republic;
Hop Univ Geneve Unite Oncohematol Pediat Geneva Switzerland;
Dmitriy Rogachev Natl Ctr Pediat Hematol Oncol &
Dept Hematopoiet Stem Cell Transplantat Minsk;
Dmitriy Rogachev Natl Ctr Pediat Hematol Oncol &
Dept Hematopoiet Stem Cell Transplantat Minsk;
Sorbonne Univ Serv Neurol 2 Mazarin Hop Univ La Pitie Salpetriere Charles Foix Inserm CNRS UMR S;
Great Ormond St Hosp London Dept Pediat Hemato Oncol London England;
St Anna Childrens Hosp Dept Pediat Oncol &
Hematol Vienna Austria;
Univ Paris Sorbonne Cite CNRS SNC 5014 INSERM UMR S1147 Paris France;
Newcastle Univ Inst Cellular Med Newcastle Upon Tyne Tyne &
Wear England;
PIFO Univ Versailles St Quentin CHU R Poincare Fac Med Serv Pharmacol Toxicol Garches France;
Univ Paris Saclay UVSQ EA4340 Boulogne France;
Trousseau Hosp French Reference Ctr Langerhans Cell Histiocytosi Paris France;
Trousseau Hosp French Reference Ctr Langerhans Cell Histiocytosi Paris France;
机译:用BRAF抑制剂vemureafenib治疗难治性BRAF(V600E)突变的朗格汉斯细胞组织细胞症的皮肤不良事件:欧洲队列研究
机译:维拉非尼在多系统性和难治性Erdheim-Chester病以及携带BRAF V600E突变的朗格汉斯细胞组织细胞增生症中具有显着疗效。
机译:维拉非尼在多系统性和难治性Erdheim-Chester病以及携带BRAF V600E突变的朗格汉斯细胞组织细胞增生症中具有显着疗效。
机译:越南儿童朗格汉斯细胞组织菌病病理特征及BRAF v600E状态研究
机译:携带BRAF V600E突变的严重皮肤朗格汉斯细胞组织细胞增生症患者对vemurafenib的主要反应